Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially … JR Morgan, BR Schackman, JA Leff, BP Linas, AY Walley Journal of substance abuse treatment 85, 90-96, 2018 | 292 | 2018 |
Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011–2015: A Capture–Recapture Analysis JA Barocas, LF White, J Wang, AY Walley, MR LaRochelle, D Bernson, ... American Journal of Public Health 108 (12), 1675-1681, 2018 | 148 | 2018 |
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort JR Morgan, BR Schackman, ZM Weinstein, AY Walley, BP Linas Drug and alcohol dependence 200, 34-39, 2019 | 130 | 2019 |
Who to test and how to test for chronic hepatitis C infection–2016 WHO testing guidance for low-and middle-income countries PJ Easterbrook, WHOGD Group Journal of Hepatology 65 (1), S46-S66, 2016 | 128 | 2016 |
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection BP Linas, DM Barter, JR Morgan, MT Pho, JA Leff, BR Schackman, ... Annals of internal medicine 162 (9), 619-629, 2015 | 125 | 2015 |
Classification and regression tree analysis JR Morgan Technical report, 2014 | 123 | 2014 |
Antibiotics for respiratory tract infections: a comparison of prescribing in an outpatient setting TF Barlam, JR Morgan, LM Wetzler, CL Christiansen, ML Drainoni infection control & hospital epidemiology 36 (2), 153-159, 2015 | 71 | 2015 |
Predictors of frequent emergency room visits among a homeless population K Thakarar, JR Morgan, JM Gaeta, C Hohl, ML Drainoni PloS one 10 (4), e0124552, 2015 | 70 | 2015 |
Patient Outcomes Following Total Joint Replacement Surgery: A Comparison of Hospitals and Ambulatory Surgery Centers K Carey, JR Morgan, MY Lin, MS Kain, WR Creevy The Journal of arthroplasty 35 (1), 7-11, 2020 | 62 | 2020 |
Economic evaluation of HCV testing approaches in low and middle income countries JR Morgan, M Servidone, P Easterbrook, BP Linas BMC Infectious Diseases 17 (1), 697, 2017 | 55 | 2017 |
Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis JA Barocas, JR Morgan, J Wang, D McLoone, A Wurcel, MD Stein Clinical Infectious Diseases 72 (3), 472-478, 2021 | 52 | 2021 |
Projected Estimates of Opioid Mortality After Community-Level Interventions BP Linas, A Savinkina, R Madushani, J Wang, GE Yazdi, A Chatterjee, ... JAMA network open 4 (2), e2037259-e2037259, 2021 | 50 | 2021 |
Homelessness, HIV, and Incomplete Viral Suppression K Thakarar, JR Morgan, JM Gaeta, C Hohl, ML Drainoni Journal of Health Care for the Poor and Underserved 27 (1), 145-156, 2016 | 50 | 2016 |
Will converting naloxone to over‐the‐counter status increase pharmacy sales? SM Murphy, JR Morgan, PJ Jeng, BR Schackman Health services research 54 (4), 764-772, 2019 | 33 | 2019 |
Gynecologic Outcomes After Hysteroscopic and Laparoscopic Sterilization Procedures RB Perkins, JR Morgan, TP Awosogba, S Ramanadhan, ... Obstetrics & Gynecology 128 (4), 843-852, 2016 | 33 | 2016 |
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs BR Schackman, S Gutkind, JR Morgan, JA Leff, CN Behrends, ... Drug and alcohol dependence 185, 411-420, 2018 | 31 | 2018 |
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids JA Barocas, JR Morgan, DA Fiellin, BR Schackman, GE Yazdi, MD Stein, ... International Journal of Drug Policy 72, 160-168, 2019 | 30 | 2019 |
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort JR Morgan, AY Walley, SM Murphy, A Chatterjee, SE Hadland, J Barocas, ... Drug and Alcohol Dependence 225, 108764, 2021 | 27 | 2021 |
Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting JR Morgan, JA Barocas, SM Murphy, RL Epstein, MD Stein, ... JAMA Network Open 3 (12), e2029676-e2029676, 2020 | 25 | 2020 |
Characteristics of patients who accept and decline ED rapid HIV testing EM Schechter-Perkins, E Koppelman, PM Mitchell, JR Morgan, R Kutzen, ... The American journal of emergency medicine 32 (9), 1109-1112, 2014 | 21 | 2014 |